Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is held by 1,342 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 8,947,735 | 206,465 | 2.36% | $6,913,378,662.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 6,654,913 | 6,654,913 | 0.00% | $5,141,851,981.00 |
| State Street Corp | 31 Mar, 2026 | 4,664,478 | 3,670 | 0.08% | $3,603,962,282.00 |
| DODGE & COX | 31 Mar, 2026 | 4,458,238 | -138,120 | -3.00% | $3,444,613,008.00 |
| Jpmorgan Chase & Co | 31 Mar, 2026 | 4,311,806 | 371,646 | 9.43% | $3,230,794,154.00 |
| Franklin Resources Inc | 31 Mar, 2026 | 2,722,071 | 162,067 | 6.33% | $2,103,180,552.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,607,732 | 88,192 | 3.50% | $2,008,490,441.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 31 Mar, 2026 | 2,177,527 | 2,177,527 | 0.00% | $1,682,446.00 |
| Nuveen, LLC | 31 Mar, 2026 | 2,065,064 | 54,547 | 2.71% | $1,595,551,050.00 |
| LOOMIS SAYLES & CO L P | 31 Mar, 2026 | 1,912,310 | -22,016 | -1.14% | $1,477,527,279.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Mar, 2026 | 1,837,459 | 1,172,994 | 176.53% | $1,419,694,322.00 |
| Invesco Ltd. | 31 Mar, 2026 | 1,724,478 | 133,373 | 8.38% | $1,332,401,060.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 1,720,774 | 1,720,774 | 0.00% | $1,329,538,823.00 |
| FMR LLC | 31 Mar, 2026 | 1,518,192 | -801,374 | -34.55% | $1,173,016,067.00 |
| Capital World Investors | 31 Mar, 2026 | 1,419,000 | 20,997 | 1.50% | $1,096,375,503.00 |
| Morgan Stanley | 31 Mar, 2026 | 1,319,329 | -69,994 | -5.04% | $1,019,369,158.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 1,300,558 | -893,868 | -40.73% | $1,004,863,269.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,230,996 | 235,286 | 23.63% | $945,996,016.00 |
| Bank Of America Corp /De/ | 31 Mar, 2026 | 1,189,584 | 32,158 | 2.78% | $919,120,445.00 |
| Amundi | 31 Mar, 2026 | 1,009,798 | 217,892 | 27.51% | $780,210,326.00 |